Clinical Trials Browser

Carcinoma, Squamous Cell × Drug Therapy × Thoracic × Clear all

NCT00130780 2016-01-25

Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC

Phase 2 Completed

71 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell